These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 4397540)

  • 21. Mitochondrial and peroxisomal fatty acid oxidation in liver homogenates from control and clofibrate-treated rats [proceedings].
    Thomas J; Debeer LJ; Mannaerts GP; De Schepper PJ
    Arch Int Physiol Biochim; 1979 Feb; 87(1):209-10. PubMed ID: 92279
    [No Abstract]   [Full Text] [Related]  

  • 22. Rat hepatocyte peroxisomes: ultrastructural alterations following cessation of chronic dietary clofibrate administration.
    Hartman HA; Tousimis AJ
    Experientia; 1969 Dec; 25(12):1248-9. PubMed ID: 5365841
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hypocholesteremic and hypolipemic effects of p-chlorophenoxy-alpha-isobutyrate of 3-hydroxymethylpyridine hydrochloride].
    Marmo E; Imperatore AM; Caputi A; Cataldi S
    Farmaco Prat; 1971 Oct; 26(10):557-84. PubMed ID: 5157541
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of ethyl p-chlorophenoxyisobutyrate on rat adipose lipoprotein lipase activity.
    Tolman EL; Tepperman HM; Tepperman J
    Am J Physiol; 1970 May; 218(5):1313-8. PubMed ID: 4314568
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in enzyme activities of rat liver peroxisomes under various physiological conditions.
    Hayashi H; Suga T; Niinobe S
    J Biochem; 1973 Aug; 74(2):393-5. PubMed ID: 4148593
    [No Abstract]   [Full Text] [Related]  

  • 26. Stimulation of liver catalase synthesis in rats by ethyl-alpha-p-chlorophenoxyisobutyrate.
    Reddy J; Chiga M; Svoboda D
    Biochem Biophys Res Commun; 1971 Apr; 43(2):318-24. PubMed ID: 4996023
    [No Abstract]   [Full Text] [Related]  

  • 27. Newer hypolipidemic agents.
    Kritchevsky D
    Fed Proc; 1971; 30(3):835-40. PubMed ID: 4996475
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
    Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
    Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic peroxisome proliferation: induction by BR-931, a hypolipidemic analog of WY-14,643.
    Reddy JK; Azarnoff DL; Sirtori CR
    Arch Int Pharmacodyn Ther; 1978 Jul; 234(1):4-14. PubMed ID: 708142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of clofibrate (ethyl-chlorophenoxyisobutyrate) feeding on glycolytic and lipogenic enzymes and hepatic glycogen synthesis in the rat.
    Zakim D; Paradini RS; Herman RH
    Biochem Pharmacol; 1970 Jan; 19(1):305-10. PubMed ID: 5507646
    [No Abstract]   [Full Text] [Related]  

  • 31. Microbodies in experimentally altered cells. 8. Continuities between microbodies and their possible biologic significance.
    Reddy J; Svoboda D
    Lab Invest; 1971 Jan; 24(1):74-81. PubMed ID: 4322703
    [No Abstract]   [Full Text] [Related]  

  • 32. [Mechanism of action of clofibrate].
    Lang PD
    Ther Ggw; 1975 Feb; 114(2):204-6, 208-10, 212-4. PubMed ID: 1118816
    [No Abstract]   [Full Text] [Related]  

  • 33. Peroxisome enzyme modification and oxidative stress in rat by hypolipidemic and antiinflammatory drugs.
    Rivero A; Monreal JI; Gil MJ
    Rev Esp Fisiol; 1994 Dec; 50(4):259-68. PubMed ID: 7754169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic microbody proliferation and catalase synthesis induced by methyl clofenapate, a hypolipidemic analog of CPIB.
    Reddy JK
    Am J Pathol; 1974 Apr; 75(1):103-18. PubMed ID: 4825610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands.
    Svoboda D; Azarnoff D; Reddy J
    J Cell Biol; 1969 Mar; 40(3):734-46. PubMed ID: 5765763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ethanol metabolism in rats treated with ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate).
    Kähönen MT; Ylikahri RH; Hassinen I
    Life Sci II; 1971 Jun; 10(12):661-70. PubMed ID: 5560535
    [No Abstract]   [Full Text] [Related]  

  • 37. The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid, and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes.
    Moody DE; Reddy JK
    Am J Pathol; 1978 Feb; 90(2):435-46. PubMed ID: 623209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of atromid-S and high fat diet on lipid contents and lipolysis in rat tissues and serum.
    Grafnetter D; Mrhová O; Janda J
    Arch Int Pharmacodyn Ther; 1971 Mar; 190(1):159-73. PubMed ID: 5551199
    [No Abstract]   [Full Text] [Related]  

  • 39. Relative contribution of mitochondria and peroxisomes to overall fatty acid oxidation in isolated hypatocytes [proceedings].
    Thomas J; Debeer LJ; De Schepper PJ; Mannaerts GP
    Arch Int Physiol Biochim; 1979 May; 87(2):426-8. PubMed ID: 92968
    [No Abstract]   [Full Text] [Related]  

  • 40. Structure of hepatic microbodies in rats treated with acetylsalicylic acid, clofibrate, and dimethrin.
    Hruban Z; Gotoh M; Slesers A; Chou SF
    Lab Invest; 1974 Jan; 30(1):64-75. PubMed ID: 4812810
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.